Owner Allergan, Inc.

Inventors Burke, James A; De Vries, Gerald W.; Lin, Ton; Wheeler, Larry A.

Agent Davies Collison Cave

Pub. Number AU-B-2002230567

PCT Pub. Number WO02/36162

Priority 60/244,850 01.11.00 US

Filing date 1 November 2001

Wipo publication date 15 May 2002

Acceptance publication date 18 January 2007

C07D 233/50 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/00 (2006.01)

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4168 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/57 (2006.01) Medicinal preparations containing peptides

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/14 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 39/00 (2006.01) General protective or antinoxious agents

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group